ACET FY 2022 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$76M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$25M+156.8% YoY

Gross Profit

$25M100.0% margin

Operating Income

-$73M-290.3% margin

Net Income

-$70M-279.3% margin

EPS (Diluted)

$-27.20

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$62M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$331M

Total Liabilities

$38M

Stockholders' Equity

$292M

Cash & Equivalents

$258M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$10M	+156.8%
Gross Profit	$25M	$10M	+156.8%
Operating Income	-$73M	-$61M	-18.1%
Net Income	-$70M	-$62M	-12.6%